welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Sarepta Therapeutics Announces Recipients of Route 79, the Duchenne Scholarship Program


Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced 21 recipients of Route 79, The Duchenne Scholarship Program. This is the third year of the scholarship program, which was created to recognize exceptional individuals with Duchenne muscular dystrophy as they pursue their post-secondary education. Recipients were chosen by an independent selection committee composed of Duchenne community members, who consider each applicant’s community involvement and a personal essay. Each student will receive a scholarship of up to $5,000.

“It is our great privilege to announce and congratulate the 2020 recipients of Route 79, The Duchenne Scholarship Program. With each new class of applicants, we are reminded of the varied interests, skills, and goals of these bright young people. Their perseverance and resiliency, particularly in the face of the challenges and uncertainties brought on by COVID, set a powerful example for others living with Duchenne,” said Diane Berry, Sarepta’s Senior Vice President of Global Health Policy, Government and Patient Affairs.

Sarepta Therapeutics Announces Recipients Of Route 79, The Duchenne Scholarship Program

rareRelated